A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the <it>HER2</it> gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections
<p>Abstract</p> <p>Background</p> <p>The eligibility of breast cancer patients for human epidermal growth factor receptor 2 (HER2)-directed therapies is determined by the <it>HER2</it> gene amplification and/or HER2 protein overexpression status of the breas...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://www.diagnosticpathology.org/content/7/1/60 |